Intellia Therapeutics Inc buy Chardan Capital
Start price
27.10.25
/
50%
€12.31
Target price
27.10.26
€41.25
Performance (%)
-8.16%
Price
10:19
€11.31
Summary
This prediction is currently active. With a performance of -8.16%, the BUY prediction for Intellia Therapeutics Inc by Chardan_Capital is down slightly. This prediction currently runs until 27.10.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -5.055% | -5.055% |
| iShares Core DAX® | -2,53 % | -5,19 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % |
| iShares S&P 500 | -0,80 % | 0,16 % |
Comments by Chardan_Capital for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) had its price target lowered by analysts at Chardan Capital from $60.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€11.72
27.02.26
27.02.26
€22.04
27.02.27
27.02.27
-6.14%
10:19
10:19
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.60
09.05.25
09.05.25
€60.64
09.05.26
09.05.26
44.74%
10:19
10:19
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.69
28.02.25
28.02.25
€65.29
28.02.26
28.02.26
13.42%
01.03.26
01.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.46
18.11.24
18.11.24
€86.10
18.11.25
18.11.25
-46.48%
19.11.25
19.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.98
07.08.23
07.08.23
€97.28
07.08.24
07.08.24
-45.29%
08.08.24
08.08.24